PET nuclear medicine procedure is used to determine the metabolic activity of the cells in the body. Positron emission tomography (PET) scan, an imaging test helps in understanding the tissues and organs functioning in the patient. It helps in diagnosing, evaluating and treating a variety of diseases.
MARKET DYNAMICS
The PET nuclear medicine market is driving due to the growing incidence and prevalence of target health conditions, and increasing number of PET procedures. However, short half-life of radiopharmaceuticals may hamper the growth of the global PET nuclear medicine market.
MARKET SCOPE
The "PET nuclear medicine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PET nuclear medicine market with detailed market segmentation by type and application. The PET nuclear medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PET nuclear medicine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The PET nuclear medicine market is segmented on the basis of type and application. Based on type, the market is segmented as F-18, Rb-82, Other PET Isotopes. On the basis of application, the market is categorized as oncology, cardiology, neurology, and other pet applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PET nuclear medicine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PET nuclear medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting PET nuclear medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PET nuclear medicine market in these regions.
MARKET PLAYERS
The report covers key developments in the PET nuclear medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PET nuclear medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for PET nuclear medicine in the global market. Below mentioned is the list of few companies engaged in the PET nuclear medicine market.
The report also includes the profiles of key players in PET nuclear medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Cardinal Health
- Curium
- GE Healthcare
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.P.A.
- Eczacibasi-Monrol Nuclear Products
- Nordion, Inc. (A Subsidiary of Sterigenics International)
- Advanced Accelerator Applications (AAA) (A Part of Novartis)
- NTP Radioisotopes Soc, LTD.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.